Distinguishing schizophrenia from posttraumatic stress disorder with psychosis

Current Opinion in Psychiatry

Volumn 28, Issue 3, 2015, Pages 249-255

  OConghaile, Aengus ^a,b,c   DeLisi, Lynn E ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Harvard Southshore Residency Training Program   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

posttraumatic stress disorder; psychosis; schizophrenia; trauma

Indexed keywords

NEUROLEPTIC AGENT; PRAZOSIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR;

COMORBIDITY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; GENETIC ASSOCIATION; HUMAN; POSTTRAUMATIC STRESS DISORDER; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SYMPTOMATOLOGY; THEORY; DIFFERENTIAL DIAGNOSIS; GENOME-WIDE ASSOCIATION STUDY; PSYCHOLOGY; PSYCHOTIC DISORDERS; STATISTICS AND NUMERICAL DATA; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES; VETERAN;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STRESS DISORDERS, POST-TRAUMATIC; UNITED STATES; VETERANS;

EID: 84926294055     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000158     Document Type: Review

References (77)

1. APA. Diagnostic and statistical manual of disease V. 5th ed. APA; 2014.
2. Lindley SE, Carlson EB, Hill KR. Psychotic-like experiences, symptom expression, and cognitive performance in combat veterans with posttraumatic stress disorder. J Nerv Ment Dis 2014; 202: 91-96.
3. Bosson JV, Reuther ET, Cohen AS. The comorbidity of psychotic symptoms and posttraumatic stress disorder: evidence for a specifier in DSM-5. Clin Schizophr Relat Psychoses 2011; 5: 147-154.
4. Blevins CA, Weathers FW, Witte TK. Dissociation and posttraumatic stress disorder: a latent profile analysis. J Trauma Stress 2014; 27: 388-396.
5. Schneider G. On several complications of neuroleptic treatment. Schweiz Arch Neurol Neurochir Psychiatr 1959; 84: 329-337.
6. Braakman MH, Kortmann FA, van den Brink W. Validity of 'posttraumatic stress disorder with secondary psychotic features': a review of the evidence. Acta Psychiatr Scand 2009; 119: 15-24.
7. Gaudiano BA, Zimmerman M. Evaluation of evidence for the psychotic subtyping of posttraumatic stress disorder. Br J Psychiatry 2010; 197: 326-327.
8. Brewin CR, Patel T. Auditory pseudohallucinations in United Kingdom war veterans and civilians with posttraumatic stress disorder. J Clin Psychiatry 2010; 71: 419-425.
9. Hamner MB, Frueh BC, Ulmer HG, et al. Psychotic features in chronic posttraumatic stress disorder and schizophrenia: comparative severity. J Nerv Ment Dis 2000; 188: 217-221.
10. Sareen J, Cox BJ, Goodwin RD, et al. Co-occurrence of posttraumatic stress disorder with positive psychotic symptoms in a nationally representative sample. J Trauma Stress 2005; 18: 313-322.
11. Hamner MB, Frueh BC, Ulmer HG, et al. Psychotic features in chronic posttraumatic stress disorder and schizophrenia: comparative severity. J Nerv Ment Dis 2000; 188: 217-221.
12. Hamner MB. Psychotic features and combat-associated PTSD. Depress Anxiety 1997; 5: 34-38.
13. Sautter FJ, Brailey K, Uddo MM, et al. PTSD and comorbid psychotic disorder: comparison with veterans diagnosed with PTSD or psychotic disorder. J Trauma Stress 1999; 12: 73-88.
14. Pivac N, Kozaric-Kovacic D, Grubisic-Ilic M, et al. The association between brain-derived neurotrophic factor Val66Met variants and psychotic symptoms in posttraumatic stress disorder. World J Biol Psychiatry 2012; 13: 306-311.
15. Pae CU, Lim HK, Peindl K, et al. The atypical antipsychotics olanzapine and risperidone in the treatment of posttraumatic stress disorder: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Clin Psychopharmacol 2008; 23: 1-8.
16. Braakman MH, Kortmann FA, van den Brink W, Verkes RJ. Posttraumatic stress disorder with secondary psychotic features: neurobiological findings. Prog. Brain Res 2008; 167: 299-302.
17. Norredam M, Jensen M, Ekstrom M. Psychotic symptoms in refugees diagnosed with PTSD: a series of case reports. Nord J Psychiatry 2011; 65: 283-288.
18. Bechdolf A, Thompson A, Nelson B, et al. Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand 2010; 121: 377-384.
19. Saha S, Whiteford H, McGrath J. Modelling the incidence and mortality of psychotic disorders: data from the second Australian national survey of psychosis. Aust N Z J Psychiatry 2014; 48: 352-359.
20. Russo DA, Stochl J, Painter M, et al. Trauma history characteristics associated with mental states at clinical high risk for psychosis. Psychiatry Res 2014; 27: 237-244.
21. Hoagland H. Schizophrenia and stress. Sci Am 1949; 181: 44-47.
22. Malmo RB, Shagass C. Physiologic studies of reaction to stress in anxiety and early schizophrenia. Psychosom Med 1949; 11: 9-24.
23. Pierre JM. Hallucinations in nonpsychotic disorders: toward a differential diagnosis of 'hearing voices'. Harv Rev Psychiatry 2010; 18: 22-35.
24. Scott JG, Nurcombe B, Sheridan J, McFarland M. Hallucinations in adolescents with posttraumatic stress disorder and psychotic disorder. Australas Psychiatry 2007; 15: 44-48.
25. Mueser KT, Rosenberg SD, Goodman LA, Trumbetta SL. Trauma, PTSD, and the course of severe mental illness: an interactive model. Schizophr Res 2002; 12002; 53 (1-2): 123-143.
26. Adeponle AB, Thombs BD, Groleau D, et al. Using the cultural formulation to resolve uncertainty in diagnoses of psychosis among ethnoculturally diverse patients. Psychiatr Serv 2012; 1: 2012; 63: 147-153.
27. Brunet K, Birchwood M, Upthegrove R, et al. A prospective study of PTSD following recovery from first-episode psychosis: the threat from persecutors, voices, and patienthood. Br J Clin Psychol 2012; 51: 418-433.
28. Berry K, Ford S, Jellicoe-Jones L, Haddock G. PTSD symptoms associated with the experiences of psychosis and hospitalisation: a review of the literature. Clin Psychol Rev 2013; 33: 526-538.
29. Bozkurt H, Mutluer TD, Kose C, Zoroglu S. High psychiatric comorbidity in adolescents with dissociative disorders. Psychiatry Clin Neurosci 2014. [Epub ahead of print]
30. Steel C, Haddock G, Tarrier N, et al. Auditory hallucinations and posttraumatic stress disorder within schizophrenia and substance abuse. J Nerv Ment Dis 2011; 199: 709-711.
31. Alvarez MJ, Roura P, Foguet Q, et al. Posttraumatic stress disorder comorbidity and clinical implications in patients with severe mental illness. J Nerv Ment Dis 2012; 200: 549-552.
32. Lu W, Mueser KT, Shami A, et al. Posttraumatic reactions to psychosis in people with multiple psychotic episodes. Schizophr Res 2011; 127 (1-3): 66-75.
33. Sin GL, Abdin E, Lee J, et al. Prevalence of posttraumatic stress disorder in first-episode psychosis. Early Interv Psychiatry 2010; 4: 299-304.
34. Lommen MJ, Restifo K. Trauma and posttraumatic stress disorder (PTSD) in patients with schizophrenia or schizoaffective disorder. Community Ment Health J 2009; 45: 485-496.
35. Picken A, Tarrier N. Trauma and comorbid posttraumatic stress disorder in individuals with schizophrenia and substance abuse. Compr Psychiatry 2011; 52: 490-497.
36. Bendall S, Alvarez-Jimenez M, Hulbert CA, et al. Childhood trauma increases the risk of posttraumatic stress disorder in response to first-episode psychosis. Aust N Z J Psychiatry 2012; 46: 35-39.
37. Bendall S, Hulbert CA, Alvarez-Jimenez M, et al. Testing a model of the relationship between childhood sexual abuse and psychosis in a first-episode psychosis group: the role of hallucinations and delusions, posttraumatic intrusions, and selective attention. J Nerv Ment Dis 2013; 201: 941-947.
38. Dvir Y, Denietolis B, Frazier JA. Childhood trauma and psychosis. Child Adolesc Psychiatr Clin N Am 2013; 22: 629-641.
39. Frounfelker R, Klodnick VV, Mueser KT, Todd S. Trauma and posttraumatic stress disorder among transition-age youth with serious mental health conditions. J Trauma Stress 2013; 26: 409-412.
40. Fisher HL, Caspi A, Poulton R, et al. Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study. Psychol Med 2013; 43: 2077-2086.
41. Rahmani M, Paul S, Nguyen ML. Treatment of refractory substance-induced psychosis in adolescent males with a genetic predisposition to mental illness. Int J Adolesc Med Health 2014; 26: 297-301.
42. Rognli EB, Hakansson A, Berge J, Bramness JG. Does the pattern of amphetamine use prior to incarceration predict later psychosis?-a longitudinal study of amphetamine users in the Swedish criminal justice system. Drug Alcohol Depend 2014; 143: 219-224.
43. Biederman J, Petty C, Spencer TJ, et al. Is ADHD a risk for posttraumatic stress disorder (PTSD)? Results from a large longitudinal study of referred children with and without ADHD. World J Biol Psychiatry 2014; 15: 49-55.
44. Maibing CF, Pedersen CB, Benros ME, et al. Risk of schizophrenia increases after all child and adolescent psychiatric disorders: a nationwide study. Schizophr Bull 2014. [Epub ahead of print]
45. Osenbach JE, Lewis C, Rosenfeld B, et al. Exploring the longitudinal trajectories of posttraumatic stress disorder in injured trauma survivors. Psychiatry 2014; 77: 386-397.
46. Duncan L, Nievergelt C, Ripke S, et al. GWAS of posttraumatic stress disorder: First report of the psychiatric genomics consortium-PTSD group. Copenhagen, Denmark: The XXIInd World Congress of Psychiatric Genetics; 2004.
47. Nievergelt CM, Maihofer AX, Mustapic M, et al.Genomic predictors of combat stress vulnerability and resilience in U.S. Marines: A genome-wide association study across multiple ancestries implicates PRTFDC1 as a potential PTSD gene. Psychoneuroendocrinology 2015; 51: 459-471.
48. Sautter FJ, Cornwell J, Johnson JJ, et al. Family history study of posttraumatic stress disorder with secondary psychotic symptoms. Am J Psychiatry 2002; 159: 1775-1777.
49. Lyons MJ, Huppert J, Toomey R, et al. Lifetime prevalence of mood and anxiety disorders in twin pairs discordant for schizophrenia. Twin Res 2000; 3: 28-32.
50. Sautter FJ, Bissette G, Wiley J, et al. Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects. Biol Psychiatry 2003; 15: 2003; 54: 1382-1388.
51. Aas M, Haukvik UK, Djurovic S, et al. BDNF val66met modulates the association between childhood trauma, cognitive and brain abnormalities in psychoses. Prog Neuropsychopharmacol Biol Psychiatry 2013; 46: 181-188.
52. Buckley PF, Pillai A, Howell KR. Brain-derived neurotrophic factor: findings in schizophrenia. Curr Opin Psychiatry 2011; 24: 122-127.
53. Sun MM, Liu LF, Yang LM, et al. Association study of brain-derived neurotrophic factor Val66Met polymorphism and clinical characteristics of first episode schizophrenia. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2012; 29: 155-158.
54. Klimek V, Rajkowska G, Luker SN, et al. Brain noradrenergic receptors in major depression and schizophrenia. Neuropsychopharmacology 1999; 21: 69-81.
55. Liberzon I, King AP, Ressler KJ, et al. Interaction of the ADRB2 gene polymorphism with childhood trauma in predicting adult symptoms of posttraumatic stress disorder. JAMA Psychiatry 2014; 71: 1174-1182.
56. Bajor LA, Ticlea AN, Osser DN. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on posttraumatic stress disorder. Harv Rev Psychiatry 2011; 19: 240-258.
57. Raskind MA, Peskind ER, Kanter ED, et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry 2003; 160: 371-373.
58. Writer BW, Meyer EG, Schillerstrom JE. Prazosin for military combat-related PTSD nightmares: a critical review. J Neuropsychiatry Clin Neurosci 2014; 26: 24-33.
59. Wadenberg ML, Hertel P, Fernholm R, et al. Enhancement of antipsychoticlike effects by combined treatment with the alpha1-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats. J Neural Transm 2000; 107: 1229-1238.
60. Abraham R, Nirogi R, Shinde A, Irupannanavar S. Low-dose prazosin in combination with 5-HT6 antagonist PRX-07034 has antipsychotic effects. Can J Physiol Pharmacol 2015; 93: 13-21.
61. Waltereit R, Eifler S, Schirmbeck F, Zink M. Visual and auditory hallucinations associated with citalopram treatment. J Clin Psychopharmacol 2013; 33: 583-584.
62. Capaldi VF 2nd, Carr RB. Citalopram-induced hallucinations and delusions in a young adult. Gen Hosp Psychiatry 2010; 32: 648; e641-643.
63. Wand AP. Transient citalopram-induced auditory hallucinations in a patient with Parkinson's disease and depression. Aust N Z J Psychiatry 2012; 46: 178.
64. Physicians Desk Reference: National Institutes of Health's Medline Plus; 2014; No. 68.
65. Kozaric-Kovacic D. Pharmacotherapy treatment of PTSD and comorbid disorders. Psychiatr Danub 2009; 21: 411-414.
66. Kozaric-Kovacic D, Pivac N. Quetiapine treatment in an open trial in combatrelated posttraumatic stress disorder with psychotic features. Int J Neuropsychopharmacol 2007; 10: 253-261.
67. Sepehry AA, Potvin S, Elie R, Stip E. Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a metaanalysis. J Clin Psychiatry 2007; 68: 604-610.
68. Hinkelmann K, Yassouridis A, Kellner M, et al. No effects of antidepressants on negative symptoms in schizophrenia. J Clin Psychopharmacol 2013; 33: 686-690.
69. Usall J, Lopez-Carrilero R, Iniesta R, et al. Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia. J Clin Psychiatry 2014; 75: 608-615.
70. Nappi CM, Drummond SP, Hall JM. Treating nightmares and insomnia in posttraumatic stress disorder: a review of current evidence. Neuropharmacology 2012; 62: 576-585.
71. Gurguis GN, Andrews R, Antai-Otong D, et al. Neutrophil beta2-adrenergic receptor coupling efficiency to Gs protein in subjects with posttraumatic stress disorder and normal controls. Psychopharmacology (Berl) 1999; 143: 131-140.
72. Wang HR, Woo YS, Bahk WM. Atypical antipsychotics in the treatment of posttraumatic stress disorder. Clin Neuropharmacol 2013; 36: 216-222.
73. Marshall AJ, Acheson DT, Risbrough VB, et al. Fear conditioning, safety learning, and sleep in humans. J Neurosci 2014; 34: 11754-11760.
74. Gupta MA, Simpson FC. Obstructive sleep apnea and psychiatric disorders: a systematic review. J Clin Sleep Med 2015; 11: 165-175.
75. Heinzelmann M, Lee H, Rak H, et al. Sleep restoration is associated with reduced plasma C-reactive protein and depression symptoms in military personnel with sleep disturbance after deployment. Sleep Med 2014; 15: 1565-1570.
76. Afonso P, Figueira ML, Paiva T. Sleep-wake patterns in schizophrenia patients compared to healthy controls. World J Biol Psychiatry 2014; 15: 517-524.
77. Waldrop AE, Back SE, Sensenig A, Brady KT. Sleep disturbances associated with posttraumatic stress disorder and alcohol dependence. Addict Behav 2008; 33: 328-335.